Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell LymphomasMichele Merli, Luca Arcaini, Lucia Farina et al.|The Oncologist|2018Cited by 69
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphomaAlessandro Loglio, Pietro Lampertico, Mauro Viganò et al.|Digestive and Liver Disease|2018Cited by 16
P0655 : Lamivudine prophylaxis prevents hepatitis B reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non-Hodgkin's B cell lymphomaMauro Viganò, Pietro Lampertico, G. Grossi et al.|Journal of Hepatology|2015Cited by 4
Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphomaMauro Viganò, Pietro Lampertico, G. Grossi et al.|Digestive and Liver Disease|2015Cited by 3